《數字化中藥材標準》由國家藥典委員會主編。旨在建立數字化的我國各級中藥材品質標準體系，為海內外用戶提供圍繞中藥材標準的全數字化出版物和信息增值服務。
數字化中藥材標準作為數字化時代下的國家藥品標準數字化支撐平臺，融入了特色鮮明的藥品標準“大數據”和“互聯網+”的概念。《數字化中藥材標準》共收載包括《中國藥典》最新版本在內的中藥材品種618個，相關性狀、顯微鑒別、含量測定等各類專業插圖3452幅。以及《中藥材顯微鑒別圖鑒》、《中藥材及原植物圖鑒》、《中藥材薄層色譜彩色圖集》、《高效液相色譜圖集》等藥典配套叢書及其支持數據。
數字化中藥材標準正文同時提供中、英文版本並支持雙語對比顯示。此外，軟件介面採用了中、英、法、德、日語等多種語言；還實現了對同時期《美國藥典》、《歐洲藥典》、《日本藥局方》、《印度藥典》、《越南藥典》、《韓國藥典》等各國藥典關於中藥材（植物藥）品質標準收載情況的統計。提供中、英文版本並支持雙語對比顯示，也可顯示法、德、日等多國語言進行檢索和使用。該數字出版物的面世將全面滿足藥品監管、檢驗、科研、教學，以及科普等各領域對於中藥材標準信息化、數字化的需求，為全行業提供圍繞藥品標準的一站式解決方案和信息增值服務。
Digitized Standards for Chinese Materia Medica was compiled by the Chinese Pharmacopoeia Commission. This bilingual Digitized Standards for Chinese Materia Medica is to date the most authoritative and comprehensive digital compilation of the Chinese national drug standards in context of information age and internet plus. It is launched to provide a digital support platform for domestic and overseas users to use and research Chinese Materia Medica quality standards such as Chinese Pharmacopoeia in a systematic manner.
The Digital Standards for Chinese Materia Medica includes the varieties of Chinese Materia Medica recorded in the volume I of the Chinese Pharmacopoeia and its Supplements, as well as contents of supporting series of Chinese Pharmacopoeia such as An Illustrated Handbook on Microscopic Identification of Chinese Crude Drugs, A Colored Identification Atlas of Chinese Materia Medica and Plants, Thin-layer Chromatography Atlas of Chinese Crude Drugs, High Performance Liquid Chromatography Atlas, and contains a total of 618 monographs for Chinese Materia Medica, and 3,452 various specialized illustrations for characters, microscopic identification and assay etc. The text of the Standards is available in both Chinese and English, and allows for a contrastive bilingual display. In addition, the software user interface is provided in multiple languages such as Chinese, English, French, German, and Japanese. It also collects records of the standards for traditional Chinese medicine (phytomedicine) that are maintained in the contemporary United States Pharmacopeia, European Pharmacopoeia, Japanese Pharmacopoeia, Indian Pharmacopoeia, Vietnamese Pharmacopoeia, and Korean Pharmacopoeia. The entire platform incorporated the concepts of “big data” and “internet plus” in its design and development in order to provide one-stop solutions and value-added information services associated with drug standards for the entire industry.
|